.png)
Healthcare PR
From regional pharmacy to national clinical AI authority
The campaign generated 54.4M audience reach and 256K earned media views with zero negative coverage—establishing credibility in one of the most scrutinized sectors of healthcare technology: clinical AI.
Narrative alignment with measurable outcomes—including 90% reduction in provider research time, 50% adherence improvement, and 99% patient satisfaction—anchored media coverage in clinical proof rather than speculative AI claims.
Credibility-first positioning supported 3,416% revenue growth over three years, amplified enterprise partnerships with CareFirst BCBS and Otsuka Precision Health, and elevated CaryHealth to Inc. 5000 rankings (#96 overall, #2 among AI companies)—demonstrating the business impact of trust-driven communications.
THE
CHALLENGE
CaryHealth entered 2023 with a bold ambition: evolve from a regional digital pharmacy into a national AI-powered clinical intelligence platform.
The opportunity was significant—but so was the credibility gap.
The healthcare AI market was flooded with solutions making aggressive claims, while clinicians remained deeply skeptical of AI “hallucinations” that could compromise patient safety. At the same time, providers were spending up to 90% of their research time navigating fragmented clinical databases, and medication non-adherence continued to cost the U.S. healthcare system more than $300B annually.
CaryHealth needed to:
Establish clinical trust in a high-scrutiny AI environment
Translate complex AI infrastructure into credible, clinician-friendly narratives
Create and define a new category beyond pharmacy apps or EHR tools
Elevate CEO Areo Nazari into a national thought leader
Shed its regional perception and gain enterprise-level credibility
Society22 PR was engaged to build trust first—then scale visibility.
THE SOCIETY22
APPROACH
Society22 PR executed a phased strategy focused on credibility, category creation, and sustained authority.
Foundational positioning and trust building
Society22 PR developed the “Zero Hallucination AI” positioning—anchoring CaryHealth’s story in clinical accuracy, evidence-based intelligence, and patient safety. Messaging reframed the company as the clinical intelligence layer connecting providers, pharmacies, payers, and patients.
Complex AI capabilities—including analysis of 200M+ clinical studies, 147K FDA inserts, and millions of drug interactions—were translated into clear, defensible proof points without sacrificing technical credibility.
CEO Areo Nazari was positioned as an emerging authority on AI safety, medication adherence, and clinician efficiency.
Product launch amplification and growth signaling
Product launches were framed around solving urgent healthcare problems, not introducing new tools.
The Clair AI platform was positioned as a solution to clinician research inefficiency, while CaryRx was introduced as an extension of the intelligence ecosystem—connecting clinical insight directly to prescription fulfillment and adherence.
Growth milestones, including Inc. 5000 recognition and enterprise partnerships, were leveraged as validation signals to reinforce credibility with providers, investors, and partners.
Awards, partnerships, and enterprise validation
Society22 PR executed a targeted awards and recognition strategy to secure third-party validation, while amplifying partnerships with CareFirst BCBS and Otsuka Precision Health as enterprise proof.
Conference participation and sponsorships reinforced CaryHealth’s positioning alongside established healthcare quality organizations.
THE
RESULTS
Coverage and visibility
54.4M total audience reach across healthcare, AI, business, and regional media
256K earned media views
Consistent coverage emphasizing clinical accuracy, evidence-based AI, and safety
Zero negative coverage despite operating in a high-risk healthcare AI category
Thought leadership and executive visibility
CEO Areo Nazari featured in Washington DC Economic Partnership Executive Insights
Recognition from AI TechAwards for Excellence in AI Healthcare Innovation
Inc. 5000 rankings including #96 overall, #2 among AI companies, and #6 nationally in AI
NCQA conference sponsorship positioning CaryHealth alongside established quality leaders
Business and platform impact
3,416% revenue growth over three years supported by credibility-first PR narrative
Strategic partnerships with CareFirst BCBS and Otsuka Precision Health amplified through media
Clair positioned as a zero-hallucination clinical reference platform
CaryRx launch coverage emphasized 50% adherence improvement and 99% patient satisfaction
Provider workflow optimization narrative (90% reduction in research time) consistently pulled through coverage
The Impact
Society22 PR transformed CaryHealth from an unknown regional pharmacy into a nationally recognized AI healthcare innovator.
By leading with trust, evidence, and clinical validation, the campaign reshaped how the market perceived AI in healthcare—moving the conversation from hype to safety, accuracy, and real-world outcomes.
The result was not only reach and visibility, but durable credibility with clinicians, enterprise partners, and investors—positioning CaryHealth as essential infrastructure for modern healthcare delivery.